News, Publications & Insights

Explore the latest news and publications, innovation milestones, and drug-device insights from PARI and our pharmaceutical partners leveraging eFlow® Technology.

Posts of category: Publications

Peer-reviewed research, clinical studies, and scientific papers related to eFlow® Technology and inhaled therapies.

Published

September 23, 2021

Category

Publications

Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial.

Published

September 15, 2021

Category

Publications

The Role of Suboptimal Concentrations of Nebulized Tobramycin in Driving Antimicrobial Resistance in Pseudomonas aeruginosa Isolates in Cystic Fibrosis.

Published

May 21, 2021

Category

Publications

Robustness of aerosol delivery of amikacin liposome inhalation suspension using the eFlow® Technology.

Published

March 31, 2021

Category

Publications

Improvement in Lung Function and Patient-Reported Outcomes in Patients with COPD with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies.

Published

January 4, 2021

Category

Publications

Development of an intervention to increase adherence to nebuliser treatment in adults with cystic fibrosis: CFHealthHub.